CRISPR Therapeutics Ownership & Insider Activity

CRISPR Therapeutics (CRSP) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 1.8% of shares outstanding. Institutional investors hold 64.1%.

Shares Outstanding

96.693M

Shares Float

84.454M

Insider Shares Owned

1.735M

Insider % Owned

1.8%

Institutional Shares Held

61.967M

Institutional % Held

64.1%

Ownership Breakdown

Net Insider Activity by Month

CRISPR Therapeutics Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Oct 16, 2026	Samarth Kulkarni	CHIEF EXECUTIVE OFFICER	SELL-OPTIONS	52.163K	$49.78	$2.4M
Oct 14, 2026	Simeon George	—	SELL-OPTIONS	15.486K	$31.82	$300K
Oct 13, 2026	JAMES KASINGER	GENERAL COUNSEL AND SECRETARY	SELL-OPTIONS	1.073K	$49.26	$51K
Oct 13, 2026	Samarth Kulkarni	CHIEF EXECUTIVE OFFICER	SELL-OPTIONS	4.235K	$49.26	$202K
Oct 6, 2026	JAMES KASINGER	GENERAL COUNSEL AND SECRETARY	SELL-OPTIONS	—	$36.83	$92K
Sep 22, 2026	JAMES KASINGER	GENERAL COUNSEL AND SECRETARY	SELL-OPTIONS	—	$36.93	$485K
Sep 17, 2026	Ali Behbahani	—	SELL-OPTIONS	16.321K	$35.55	$361K
May 28, 2026	Naimish Patel	CHIEF MEDICAL OFFICER	SELL-OPTIONS	6.214K	$55.62	$211K

Date	Member	Party	Chamber	Action	Amount
Sep 20, 2021	Thomas R. Suozzi	D	House	Sale	$50,001 - $100,000